S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Your Money is Not Safe (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Your Money is Not Safe (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Your Money is Not Safe (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
Your Money is Not Safe (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Free Trial
CVE:HEM

Hemostemix (HEM) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)
Free HEM Stock Alerts
C$0.05
-0.01 (-9.09%)
(As of 04/18/2024 05:18 PM ET)
Compare
Today's Range
C$0.05
▼
C$0.05
50-Day Range
C$0.05
▼
C$0.10
52-Week Range
C$0.05
▼
C$0.18
Volume
16,000 shs
Average Volume
39,595 shs
Market Capitalization
C$4.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlinesInsider Trades
HEM stock logo

About Hemostemix Stock (CVE:HEM)

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States. The company is also developing various types of cell products, such as synergetic cell populations, neural cell precursors, and cardiomyocyte cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

HEM Stock Price History

HEM Stock News Headlines

March 7, 2024 | finanznachrichten.de
Hemostemix Inc.: Hemostemix Announces Engagement of Oak Hill Asset Management Inc.
March 7, 2024 | finance.yahoo.com
Hemostemix Announces Engagement of Oak Hill Asset Management Inc.
April 19, 2024 | InvestorPlace (Ad)
You’re invited: Biggest crypto event of 2024
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
February 20, 2024 | theglobeandmail.com
Hemostemix: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (HEM)
February 19, 2024 | theglobeandmail.com
Hemostemix: Top 10 Undervalued Biotechnology Industry Stocks (HEM)
February 6, 2024 | finance.yahoo.com
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences
January 19, 2024 | morningstar.com
Hemostemix Inc HMTXF
October 30, 2023 | finanznachrichten.de
Hemostemix Inc.: Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease
April 19, 2024 | InvestorPlace (Ad)
You’re invited: Biggest crypto event of 2024
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
October 30, 2023 | finance.yahoo.com
Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease
October 20, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc down on Thursday (HEM)
August 29, 2023 | finance.yahoo.com
Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications
August 8, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc up on Friday (HEM)
June 28, 2023 | finanznachrichten.de
Hemostemix Inc.: Hemostemix Closes $403,539 of the Unit Private Placement
June 28, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc up on Tuesday (HEM)
June 28, 2023 | finance.yahoo.com
Hemostemix Closes $403,539 of the Unit Private Placement
June 27, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc down on Monday (HEM)
June 24, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc flat on Wednesday (HEM)
June 22, 2023 | marketwatch.com
Hemostemix's Private Placement Use of Proceeds
June 17, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc down on Friday (HEM)
June 2, 2023 | msn.com
Hemostemix to raise $1.2M through private placement of units
May 3, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc flat on Tuesday (HEM)
May 2, 2023 | finance.yahoo.com
Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company
April 29, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc flat on Friday (HEM)
April 21, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc flat on Thursday (HEM)
April 20, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc up on Wednesday (HEM)
April 19, 2023 | theglobeandmail.com
Closing Bell: Hemostemix Inc down on Tuesday (HEM)
See More Headlines
Receive HEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:HEM
CUSIP
N/A
CIK
N/A
Web
www.hemostemix.com
Phone
+1-403-3409207
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-3,170,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-165.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.48

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
10.77
Book Value
C($0.08) per share
Price / Book
-0.63

Miscellaneous

Outstanding Shares
89,790,000
Free Float
N/A
Market Cap
C$4.49 million
Optionable
Not Optionable
Beta
0.55
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

HEM Stock Analysis - Frequently Asked Questions

How have HEM shares performed in 2024?

Hemostemix's stock was trading at C$0.07 at the beginning of the year. Since then, HEM shares have decreased by 28.6% and is now trading at C$0.05.
View the best growth stocks for 2024 here.

When is Hemostemix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, April 19th 2024.
View our HEM earnings forecast.

What other stocks do shareholders of Hemostemix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hemostemix investors own include Iplayco (IPC), Capricor Therapeutics (CAPR), Gene Biotherapeutics (CRXM), Camber Energy (CEI), Auxly Cannabis Group (CBWTF), Cannabis Science (CBIS), Beazer Homes USA (BZH), Big Tree Group (BIGG), Asterias Biotherapeutics (AST) and

How do I buy shares of Hemostemix?

Shares of HEM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:HEM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research